1) Polymers: The Structural Backbone
- Role: Define mechanical strength, chemical/thermal stability, and the base separation scaffold. Crystallinity, molecular weight, and chain architecture govern demixing and crystallization, thus pore morphology.
- Environmental (UF/MF, MBR, wastewater): PVDF, PE, PP, PAN, PPS.
- Medical (hemodialysis/sterile filtration supports): Medical-grade PVDF, medical-grade PE, PEEK.
- Gas separation/contactors: PVDF, PP, PI, PMP, EVOH.
2) Diluents: The TIPS Engine
- Role: High-temperature solvent and phase-separation controller. Must dissolve the polymer hot, then lose compatibility on cooling to trigger demixing/crystallization.
- Desirable traits: High boiling point, thermal stability, low volatility; medical grades demand low toxicity and minimal residuals.
- Typical choices: Esters (e.g., methyl/ethyl benzoate, triacetin, triethyl citrate), ketones (e.g., benzophenone, cyclohexanone), others (e.g., γ-butyrolactone, propylene carbonate, caprolactam, methyl salicylate).
3) Nonsolvents: Thermodynamics Tuners
- Role: Blended with diluent to adjust phase equilibria and demixing rate; refine pore size and porosity uniformity; in some systems lower apparent melting ranges.
- Examples: Alcohols (octanol–decanol range, benzyl alcohol, sorbitol, mannitol), polyols (propylene glycol, glycerol, di/triethylene glycol derivatives), specialty co-modifiers (e.g., 2-hydroxy-2-phenylacetophenone for solid–liquid control).
4) Pore Formers: Connectivity Architects
- Role: Promote phase separation, boost porosity, tailor pore size/connectivity, and temper over-crystallization.
- High-molecular: PEG (MW 200–20,000), PVP (MW 10,000–150,000).
- Small-molecule: Glycerol, ethylene glycol, PPG.
- Inorganic: Inorganic: Nano-SiO₂, nano-TiO₂, CaCO₃ (dose control avoids agglomeration—especially in hemodialysis and gas applications).
5) Functional Modifiers: Application Fit Finishers
- Biocompatibility (medical): Heparin-mimetic or zwitterionic polymers (e.g., MPC-type), medicalgrade chitosan; anti-coagulation/low protein adsorption.
- Gas-selectivity tuning: Zeolites, MOFs, graphene oxide, fluorinated modifiers to balance permeability/selectivity and anti-plasticization.
- Chemical/thermal durability: Antioxidants, fluorocarbon modifiers, heat stabilizers (e.g., calcium/zinc stearates).
- Anti-fouling/anti-wetting: SPSf, HEC, modified PES, nano-SiO₂/TiO₂ to raise hydrophilicity or manage water vapor uptake by need.
- Antimicrobials: Silver nanoparticles, quaternized nanomaterials, polyphenols (e.g., gallic/tannic acid) for biofouling control.
6) Mechanical Reinforcers: Strength Without Penalty
- Role: Increase tensile strength, elongation at break, flex durability, and creep resistance while protecting core separation traits.
- Inorganic: Nano-SiO₂, nano-TiO₂, nano-ZrO₂ (typically ≤5%), short carbon fibers.
- Polymer-based: PVDF-HFP, PE-PP copolymers, PEEK micropowders (targeted to medical/gas membranes).
7) Spinning Aids: Dope and Fiber-Forming Stabilizers
- Role: Fine-tune rheology, roundness, skin integrity, bubble suppression; typical dosages ≤1%.
- Rheology modifiers: Low-MW polyolefin waxes, hydrogenated castor oil.
- Surface-tension reducers: Medical-grade PEG fatty acid esters, low-volatility silicone surfactants.
- Defoamers: Medical-grade polyether types, low-volatility silicones.
- Stabilizers/antistats: Antioxidants, light stabilizers; cationic antistats or polyetheramine antistats for high-temperature spinning.
8) Process Fluids: Shape and Skin Designers
- Bore fluids (inner cooling/shaping): Air (ambient/low-temp), glycerol–water (humid, slower cool), diluent–water blends (delay inner crystallization for more open inner pores).
- External quench/cooling baths: Deionized water (0–60°C, controlled), optionally with minor alcohols (ethanol, propylene glycol) to tune cooling rate and skin formation.
9) Post-Treatment Agents: From Green Fiber to Stable Product
- Extractants: Ethanol, isopropanol, n-hexane to remove residual diluent; sterile handling for medical grades.
- Washes: Deionized water; light alkali for environmental membranes where appropriate.
- Fixing/crosslinking: EGDE, glutaraldehyde, or thermal annealing to lock pore geometry and chemical resistance ,For TIPS hollow fiber membrane spinning machine.
- Humectants/anti-crack: Glycerol, PEG-400 to preserve wet structure during drying/storage.
- Sterilants (medical): Ethylene oxide, gamma irradiation, as specified by product class.
10) Compatibilizers & Nucleators: Morphology Managers
- Compatibilizers: MAH-g-PP, MAH-g-PE, tailored copolymers (e.g., PVDF-PE types) to harmonize blends/fillers and shrink phase domains.
- Nucleators: Inorganic (nano-CaCO₃, talc) and organic (sorbitol, phosphate esters) to accelerate crystallization and refine spherulites, strengthening the matrix.
11) Potting & Module Materials: Making Systems Work
- Potting resins: Epoxy, polyurethane, low-shrink silicone for chemical-resistant, leak-tight encapsulation.
- Housings/endcaps/seals: PC, PSU, stainless steel, PVDF; seals in EPDM or FKM for solvent-exposed service.
- Preservatives and storage media: Glycerol–water, saline, or antimicrobial holding solutions for wet-stored medical or hydrophilic products.
Comparison: Aligning Material Choices to the Application
Dimension | Environmental Filtration (UF/MF, MBR) | Medical (Hemodialysis/ Sterile Filters) | Gas Separation/Contactors |
Core polymers | PVDF, PE, PP, PAN, PPS | Medical-grade PVDF, PE, PEEK | PVDF, PP, PI, PMP, EVOH |
Diluents & nonsolvents | High-bp, recoverable; blends to balance flux/strength | Low-tox, low-residual, sterile handling | High stability; tune demixing to resist wetting |
Pore formers | PEG/PVP; optional inorganic to raise porosity | Medical-grade PEG/PVP; inorganic tightly limited | Minimal agglomeration; preserve selective skin |
Functional modifiers | Hydrophilicity, anti-fouling, oxidant tolerance | Biocompatibility, anti-protein adsorption, sterilizability | Anti-wetting, anti-plasticization, selectivity tuning |
Process fluids | Water quench (0–60°C); glycerol–water bore | Sterile bore fluids; controlled inner skin | Air or diluent–water bore; precise temperature split |
Post-treatments | Extract–wash–anneal; hydrophilic finish optional | Extract–sterilize–stabilize; residuals tightly controlled | Extract–anneal; surface energy tuned for wetting resistance |
Module materials | Solvent/oxidant-tolerant potting; robust housings | Medical-grade potting; biocompatible wetted parts | Solvent- and pressure-resistant potting; FKM seals |
Practical Selection Tips
- Start with the phase diagram in mind: pick polymer–diluent systems that give a controllable UCST/LCST window at practical spinning temperatures.
- Treat nonsolvent co-additives like a “gearbox” for demixing: small changes can shift pore scale and connectivity substantially.
- Dose pore formers conservatively, validate extraction completeness, and monitor residuals—especially for medical membranes.
- Match bore and quench temperatures to the desired skin orientation (inside-out vs. outside-in service).
- · Close the loop on extractant and diluent recovery to stabilize cost, safety, and ESG performance.